DARA BioSciences (DARA) Tops Q2 EPS by 1c

DARA BioSciences (NASDAQ: DARA) reported Q2 EPS of ($0.14), $0.01 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $990.8 thousand versus the consensus estimate of $760 thousand.

For earnings history and earnings-related data on DARA BioSciences (DARA) click here.

You May Also Be Interested In

• Ackman adds Netflix, Visa and Mastercard in portfolio revamp
• Studio City International Holdings Limited (MSC) Reports Q2 Loss of $0.02
• SPAR Group (SGRP) Reports Q2 EPS of $0.04